The indication for the Orphan Drug Designation is cholangiocarcinoma, a rare and very aggressive form of bile duct cancer which has no cure.
Please refer to our press release here (English) and here (Chinese) for more details.
The Website may contain links to or from other websites, over which ASLAN has no control. These linked sites are for your convenience only and you access them at your own risk.
ASLAN is not responsible for the content of the linked sites. ASLAN does not in any way endorse the linked sites.
Read about our latest product developments and partnerships, industry advances and events.